[April 11, 2016] |
|
Dental Caries Global Clinical Trials Review, H1, 2016 - Research and Markets
Research and Markets has announced the addition of the "Dental
Caries Global Clinical Trials Review, H1, 2016" clinical trials
to their offering.
The report provides an overview of Dental Caries clinical trials
scenario. This report provides top line data relating to the clinical
trials on Dental Caries. Report includes an overview of trial numbers
and their average enrollment in top countries conducted across the
globe. The report offers coverage of disease clinical trials by region,
country (G7 & E7), phase, trial status, end points status and sponsor
type. Report also provides prominent drugs for in-progress trials (based
on number of ongoing trials).
The report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Scope of the Report:
-
The report provides a snapshot of the global clinical trials landscape.
-
Report provides top level data related to the clinical trials by
Region, Country (G & E7), Trial Status, Trial Phase, Sponsor Type and
End point status.
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company.
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment.
-
The Report provides enrollment trends for the past five years.
-
Report provides latest news for the past three months.
Reasons to Buy:
-
Assists in formulating key business strategies with regards to
investment.
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost.
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities.
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market.
-
Aids in interpreting the success rates of clinical trials by providing
a comparative scenario of completed and uncompleted (terminated,
suspended or withdrawn) trials.
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level.
Companies Mentioned:
-
GlaxoSmithKline Plc
-
Colgate-Palmolive Company
-
C3 (News - Alert) Jian, Inc
-
GABA International AG
-
Oragenics, Inc.
-
Indiana Nanotech, LLC
-
GC Corporation
-
Advantage Dental Services, LLC
-
Agility Clinical, Inc.
-
3M (News - Alert) Company
For more information visit http://www.researchandmarkets.com/research/9tk4cp/dental_caries
View source version on businesswire.com: http://www.businesswire.com/news/home/20160411005701/en/
[ Back To TMCnet.com's Homepage ]
|